VINORELBINE

VINORELBINE was reported 6966 times

VINORELBINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERIPHERAL BLOOD STEM CELL APHERESIS 10 0.6250
1 HRD GENE MUTATION ASSAY POSITIVE 4 0.5000
2 DESMOPLASTIC SMALL ROUND CELL TUMOUR 33 0.3793
3 CONGENITAL HAEMATOLOGICAL DISORDER 4 0.3636
4 ACTIVATED PI3 KINASE DELTA SYNDROME 8 0.3478
5 HAEMATOPOIETIC STEM CELL MOBILISATION 16 0.2500
6 VACCINATION SITE HAEMORRHAGE 6 0.1667
7 TRANSAMINASES 8 0.1356
8 PIK3CA-ACTIVATED MUTATION 43 0.1295
9 NON-SMALL CELL LUNG CANCER STAGE IIIB 6 0.1224
10 PSEUDOCIRRHOSIS 39 0.1175
11 RHABDOMYOSARCOMA RECURRENT 5 0.1163
12 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT 5 0.1087
13 RETINOPATHY HAEMORRHAGIC 7 0.1061
14 HYPERFIBRINOGENAEMIA 7 0.1045
15 CANCER WITH A HIGH TUMOUR MUTATIONAL BURDEN 4 0.1026
16 LEUKONYCHIA 6 0.0952
17 CARDIAC CIRRHOSIS 8 0.0777
18 PARVOVIRUS B19 TEST POSITIVE 5 0.0704
19 AUTOIMMUNE PANCYTOPENIA 6 0.0659
20 IMMUNE-MEDIATED NEPHRITIS 30 0.0640
21 STREPTOCOCCAL ENDOCARDITIS 6 0.0632
22 CARDIAC PSEUDOANEURYSM 4 0.0580
23 MEDIASTINUM NEOPLASM 9 0.0542
24 NAIL BED INFLAMMATION 17 0.0533
25 METASTASES TO SKIN 55 0.0532
26 TRACHEAL FISTULA 8 0.0519
27 THERAPY RESPONDER 25 0.0509
28 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 9 0.0495
29 METASTASES TO SOFT TISSUE 12 0.0463
30 METASTASES TO THE MEDIASTINUM 19 0.0461
31 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA 5 0.0427
32 OOPHORITIS 6 0.0423
33 ROSEOLOVIRUS TEST POSITIVE 5 0.0410
34 HORMONE RECEPTOR POSITIVE BREAST CANCER 11 0.0404
35 NAIL AVULSION 9 0.0400
36 AUTOIMMUNE NEUTROPENIA 11 0.0381
37 NON-SMALL CELL LUNG CANCER RECURRENT 10 0.0353
38 PERIANAL ERYTHEMA 4 0.0331
39 PLANTAR ERYTHEMA 8 0.0324
40 ANAL ERYTHEMA 4 0.0320
41 CARBOHYDRATE ANTIGEN 15-3 INCREASED 24 0.0315
42 EPIPLOIC APPENDAGITIS 4 0.0312
43 DYSBIOSIS 25 0.0305
44 HYPERBARIC OXYGEN THERAPY 5 0.0301
45 ECTROPION 10 0.0297
46 EGFR GENE MUTATION 11 0.0294
47 NASAL MUCOSAL DISORDER 17 0.0292
48 ACQUIRED DIAPHRAGMATIC EVENTRATION 10 0.0282
49 GASTRIC VOLVULUS 4 0.0278
50 MEDIASTINAL DISORDER 10 0.0267
51 METASTASES TO PERITONEUM 62 0.0245
52 SUPERIOR VENA CAVA SYNDROME 14 0.0232
53 BREAST CANCER METASTATIC 249 0.0232
54 OSTEORADIONECROSIS 5 0.0225
55 BRAIN STEM ISCHAEMIA 4 0.0223
56 LYMPHANGIOSIS CARCINOMATOSA 23 0.0221
57 METASTASES TO PLEURA 23 0.0219
58 METASTASES TO LYMPH NODES 148 0.0219
59 COLD TYPE HAEMOLYTIC ANAEMIA 5 0.0213
60 RADIATION OESOPHAGITIS 8 0.0210
61 HAEMANGIOMA OF BONE 4 0.0209
62 NEUTROPENIC SEPSIS 141 0.0197
63 LUNG ADENOCARCINOMA STAGE IV 7 0.0184
64 METASTASES TO BONE MARROW 9 0.0180
65 STREPTOCOCCAL SEPSIS 21 0.0177
66 BLOOD LACTATE DEHYDROGENASE ABNORMAL 12 0.0177
67 HEPATIC CANCER RECURRENT 5 0.0176
68 METASTASES TO CHEST WALL 6 0.0173
69 LUNG ADENOCARCINOMA METASTATIC 4 0.0172
70 TUMOUR ULCERATION 4 0.0169
71 RECALL PHENOMENON 14 0.0167
72 METASTASES TO HEART 5 0.0166
73 DENTAL TREATMENT 4 0.0165
74 BREAST CANCER RECURRENT 52 0.0164
75 HEPATOSPLENIC T-CELL LYMPHOMA 6 0.0162
76 HYPERSPLENISM 8 0.0162
77 JOINT ANKYLOSIS 9 0.0158
78 METASTASES TO LUNG 183 0.0158
79 INVASIVE DUCTAL BREAST CARCINOMA 43 0.0158
80 JAW OPERATION 14 0.0157
81 BONE MARROW INFILTRATION 6 0.0155
82 METASTASES TO BONE 252 0.0153
83 METASTASES TO STOMACH 6 0.0153
84 GALLBLADDER RUPTURE 7 0.0151
85 TONSILLAR DISORDER 17 0.0151
86 SUBCLAVIAN VEIN THROMBOSIS 17 0.0149
87 NEUTROPENIC INFECTION 14 0.0146
88 RADIATION PNEUMONITIS 31 0.0145
89 METASTASES TO LIVER 254 0.0144
90 HAEMATOTOXICITY 134 0.0141
91 FOLATE DEFICIENCY 16 0.0138
92 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 13 0.0137
93 METASTASES TO CENTRAL NERVOUS SYSTEM 173 0.0134
94 PSEUDOMONAL SEPSIS 23 0.0131
95 METASTASES TO OVARY 4 0.0125
96 BONE DEBRIDEMENT 6 0.0124
97 TUMOUR PAIN 16 0.0121
98 SEQUESTRECTOMY 8 0.0120
99 CANDIDA TEST POSITIVE 5 0.0120
100 TRACHEAL STENOSIS 6 0.0118
101 ACUTE PROMYELOCYTIC LEUKAEMIA 12 0.0117
102 PERIPHERAL NERVE INJURY 10 0.0114
103 POSTRENAL FAILURE 5 0.0114
104 AORTIC THROMBOSIS 13 0.0112
105 B-CELL LYMPHOMA RECURRENT 6 0.0110
106 ALLERGY TO CHEMICALS 13 0.0104
107 AZOOSPERMIA 4 0.0104
108 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 243 0.0104
109 VENA CAVA THROMBOSIS 17 0.0102
110 GENE MUTATION 20 0.0101
111 ABDOMINAL NEOPLASM 9 0.0101
112 PERIPHERAL MOTOR NEUROPATHY 14 0.0100
113 CYTOMEGALOVIRUS CHORIORETINITIS 19 0.0097
114 DEMYELINATING POLYNEUROPATHY 10 0.0097
115 POSTICTAL STATE 10 0.0096
116 GASTROINTESTINAL TOXICITY 46 0.0096
117 GASTRIC NEOPLASM 6 0.0095
118 NON-SMALL CELL LUNG CANCER 45 0.0094
119 OSTEOLYSIS 19 0.0093
120 HYPEREOSINOPHILIC SYNDROME 5 0.0092
121 QUADRIPLEGIA 19 0.0092
122 IMMUNE-MEDIATED ADVERSE REACTION 14 0.0091
123 METASTASES TO KIDNEY 5 0.0091
124 MALIGNANT TRANSFORMATION 4 0.0089
125 POST THROMBOTIC SYNDROME 4 0.0089
126 PARANEOPLASTIC SYNDROME 6 0.0089
127 COMPUTERISED TOMOGRAM THORAX ABNORMAL 6 0.0087
128 METASTASES TO ADRENALS 8 0.0087
129 BILIARY SEPSIS 4 0.0086
130 BONE MARROW TOXICITY 10 0.0084
131 BILE DUCT STENOSIS 10 0.0083
132 EJECTION FRACTION ABNORMAL 10 0.0082
133 AXILLARY PAIN 12 0.0081
134 MUCOSAL INFLAMMATION 211 0.0081
135 ONYCHALGIA 8 0.0080
136 METASTATIC NEOPLASM 34 0.0079
137 METASTASES TO SPINE 26 0.0077
138 ASEPTIC NECROSIS BONE 6 0.0077
139 ONYCHOLYSIS 12 0.0077
140 NAIL INFECTION 11 0.0077
141 BRONCHIAL CARCINOMA 6 0.0076
142 PERIORBITAL CELLULITIS 4 0.0074
143 TRIPLE NEGATIVE BREAST CANCER 5 0.0074
144 TUMOUR FLARE 5 0.0073
145 CYTOKINE STORM 5 0.0073
146 CARDIOTOXICITY 65 0.0073
147 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 16 0.0072
148 SKIN TOXICITY 41 0.0072
149 SEROSITIS 4 0.0072
150 LUNG INFECTION PSEUDOMONAL 4 0.0072
151 URINARY TRACT INFECTION BACTERIAL 18 0.0071
152 MALIGNANT NEOPLASM PROGRESSION 710 0.0069
153 ABDOMINAL LYMPHADENOPATHY 6 0.0069
154 CEREBRAL VASOCONSTRICTION 5 0.0068
155 DISEASE PROGRESSION 789 0.0067
156 SYSTOLIC DYSFUNCTION 7 0.0066
157 PRIMARY SEQUESTRUM 6 0.0066
158 PERIPHERAL SENSORY NEUROPATHY 38 0.0065
159 NASAL DISORDER 17 0.0064
160 PARONYCHIA 28 0.0064
161 SOFT TISSUE DISORDER 7 0.0063
162 GOUTY ARTHRITIS 5 0.0063
163 EROSIVE DUODENITIS 5 0.0063
164 GINGIVAL INFECTION 5 0.0062
165 ENCEPHALITIS AUTOIMMUNE 8 0.0061
166 PULMONARY NOCARDIOSIS 5 0.0061
167 LYMPHOEDEMA 42 0.0061
168 SYSTEMIC CANDIDA 15 0.0060
169 FEBRILE INFECTION 7 0.0059
170 EJECTION FRACTION DECREASED 91 0.0058
171 PORTAL HYPERTENSION 18 0.0058
172 BREAST NEOPLASM 6 0.0058
173 ADENOCARCINOMA 13 0.0058
174 PANNICULITIS 14 0.0058
175 NON-SMALL CELL LUNG CANCER METASTATIC 5 0.0057
176 POLYNEUROPATHY 68 0.0057
177 RENAL ATROPHY 7 0.0056
178 FEBRILE NEUTROPENIA 370 0.0056
179 PERIPHERAL SENSORIMOTOR NEUROPATHY 7 0.0056
180 MALIGNANT PLEURAL EFFUSION 9 0.0053
181 HEPATORENAL SYNDROME 9 0.0053
182 LUNG ADENOCARCINOMA 16 0.0053
183 INFECTED SKIN ULCER 10 0.0053
184 THERAPY PARTIAL RESPONDER 82 0.0053
185 OSTEONECROSIS OF JAW 130 0.0052
186 DERMATITIS EXFOLIATIVE GENERALISED 18 0.0052
187 BONE MARROW FAILURE 105 0.0052
188 RECURRENT CANCER 21 0.0051
189 PNEUMONITIS 139 0.0051
190 BICYTOPENIA 10 0.0051
191 VASCULAR DEVICE INFECTION 23 0.0051
192 CELL DEATH 10 0.0050
193 NEUTROPENIA 679 0.0050
194 BONE LESION 18 0.0050
195 LYMPHANGITIS 4 0.0050
196 EXCESSIVE GRANULATION TISSUE 4 0.0050
197 ALVEOLITIS 7 0.0050
198 PNEUMOCYSTIS JIROVECII PNEUMONIA 49 0.0049
199 WHITE BLOOD CELL DISORDER 13 0.0049
200 BILIARY DILATATION 7 0.0048
201 GRANULOCYTOPENIA 27 0.0047
202 NEOPLASM RECURRENCE 16 0.0047
203 FEBRILE BONE MARROW APLASIA 20 0.0047
204 METASTASIS 33 0.0046
205 ARRHYTHMIA SUPRAVENTRICULAR 5 0.0046
206 INTESTINAL PSEUDO-OBSTRUCTION 4 0.0046
207 LEFT VENTRICULAR DYSFUNCTION 30 0.0045
208 MUSCLE NECROSIS 4 0.0044
209 URETERIC OBSTRUCTION 6 0.0044
210 METASTASES TO MENINGES 10 0.0044
211 VENOOCCLUSIVE DISEASE 11 0.0044
212 THROMBOCYTOPENIC PURPURA 6 0.0044
213 NEOPLASM PROGRESSION 152 0.0044
214 EMBOLISM VENOUS 13 0.0043
215 NEUTROPHIL COUNT ABNORMAL 12 0.0042
216 PLACENTAL DISORDER 4 0.0042
217 HYPERPHOSPHATAEMIA 9 0.0042
218 LYMPHADENOPATHY MEDIASTINAL 8 0.0042
219 TUMOUR MARKER INCREASED 20 0.0042
220 EXPOSED BONE IN JAW 9 0.0041
221 TELANGIECTASIA 4 0.0041
222 GUILLAIN-BARRE SYNDROME 20 0.0041
223 STRESS CARDIOMYOPATHY 24 0.0041
224 AREFLEXIA 11 0.0041
225 HEPATITIS B REACTIVATION 13 0.0041
226 RENAL TRANSPLANT FAILURE 4 0.0040
227 ILEUS PARALYTIC 18 0.0040
228 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 5 0.0040
229 LEUKOPENIA 200 0.0040
230 PHLEBITIS 20 0.0039
231 IMMUNE THROMBOCYTOPENIC PURPURA 11 0.0039
232 NEUTROPENIC COLITIS 8 0.0039
233 BRUGADA SYNDROME 4 0.0039
234 ACQUIRED GENE MUTATION 5 0.0038
235 LUNG CANCER METASTATIC 11 0.0038
236 OSTEOSCLEROSIS 6 0.0038
237 ASCITES 110 0.0037
238 TUMOUR PSEUDOPROGRESSION 4 0.0037
239 NEPHROPATHY TOXIC 41 0.0036
240 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
241 NEUROTOXICITY 63 0.0036
242 OESOPHAGITIS 39 0.0036
243 LYMPHOCYTE COUNT ABNORMAL 4 0.0036
244 SARCOMA 4 0.0035
245 WOUND HAEMORRHAGE 13 0.0035
246 GASTROINTESTINAL BACTERIAL INFECTION 4 0.0035
247 AUTOIMMUNE HAEMOLYTIC ANAEMIA 12 0.0035
248 VARICOSE VEIN 18 0.0035
249 MUCOSAL DRYNESS 7 0.0035
250 PLEURAL EFFUSION 211 0.0035
251 HYPERTRANSAMINASAEMIA 24 0.0034
252 BREAST DISORDER 7 0.0034
253 GASTROINTESTINAL NECROSIS 10 0.0034
254 SYSTEMIC MYCOSIS 4 0.0034
255 THROMBOCYTOPENIA 382 0.0034
256 HYPOPHOSPHATAEMIA 25 0.0034
257 JUGULAR VEIN THROMBOSIS 6 0.0034
258 PARAPARESIS 6 0.0034
259 WALKING DISABILITY 7 0.0033
260 WOUND SECRETION 13 0.0033
261 CLOSTRIDIUM DIFFICILE COLITIS 35 0.0033
262 ORAL FUNGAL INFECTION 9 0.0033
263 MONOCYTE COUNT DECREASED 4 0.0033
264 SOFT TISSUE INFECTION 6 0.0033
265 CD4 LYMPHOCYTES DECREASED 7 0.0033
266 HAEMOGLOBIN ABNORMAL 21 0.0033
267 DIFFUSE LARGE B-CELL LYMPHOMA 25 0.0032
268 SPUTUM INCREASED 7 0.0032
269 DRUG TOLERANCE DECREASED 9 0.0032
270 ATYPICAL FEMUR FRACTURE 9 0.0032
271 ODYNOPHAGIA 19 0.0032
272 CARDIAC TAMPONADE 15 0.0032
273 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
274 CARCINOEMBRYONIC ANTIGEN INCREASED 6 0.0031
275 RESPIRATORY ALKALOSIS 5 0.0031
276 ESCHERICHIA BACTERAEMIA 7 0.0030
277 DIVERTICULUM INTESTINAL 13 0.0030
278 HEPATOTOXICITY 66 0.0030
279 BLOOD LACTATE DEHYDROGENASE INCREASED 46 0.0029
280 PNEUMOTHORAX 46 0.0029
281 HYPERCHLORHYDRIA 17 0.0029
282 THROMBOPHLEBITIS 10 0.0028
283 FANCONI SYNDROME 4 0.0028
284 CARDIOPULMONARY FAILURE 11 0.0028
285 DERMATITIS ACNEIFORM 17 0.0028
286 ACUTE ABDOMEN 4 0.0027
287 PNEUMONIA KLEBSIELLA 5 0.0027
288 AMYLASE INCREASED 10 0.0027
289 HYPOALBUMINAEMIA 21 0.0027
290 PULMONARY TOXICITY 19 0.0027
291 DRUG RESISTANCE 68 0.0026
292 ACUTE MYELOID LEUKAEMIA 41 0.0026
293 ARTERIAL THROMBOSIS 5 0.0026
294 POOR PERIPHERAL CIRCULATION 11 0.0026
295 PURULENCE 5 0.0026
296 THROMBOTIC MICROANGIOPATHY 25 0.0026
297 APLASIA 5 0.0026
298 MEGACOLON 4 0.0025
299 PROSTATOMEGALY 10 0.0025
300 HEPATIC LESION 11 0.0025
301 EMPYEMA 5 0.0025
302 MYELODYSPLASTIC SYNDROME 36 0.0025
303 HICCUPS 20 0.0024
304 CAPILLARY LEAK SYNDROME 5 0.0024
305 INTERSTITIAL LUNG DISEASE 117 0.0024
306 SYSTEMIC INFECTION 4 0.0024
307 ANAEMIA 460 0.0024
308 TACHYARRHYTHMIA 6 0.0024
309 ERYSIPELAS 12 0.0024
310 OSTEITIS 6 0.0024
311 BRAIN ABSCESS 6 0.0024
312 DERMATOMYOSITIS 6 0.0024
313 CANCER PAIN 6 0.0023
314 NEUROPATHY PERIPHERAL 223 0.0023
315 LUNG NEOPLASM 10 0.0023
316 FACIAL PALSY 5 0.0023
317 EPIGASTRIC DISCOMFORT 9 0.0023
318 PERICARDIAL EFFUSION 53 0.0023
319 HYPERSENSITIVITY VASCULITIS 6 0.0023
320 DYSAESTHESIA 7 0.0023
321 ENTEROCOLITIS 13 0.0022
322 BREAST PAIN 24 0.0022
323 MYELOSUPPRESSION 81 0.0022
324 SKIN MASS 15 0.0022
325 TEMPOROMANDIBULAR JOINT SYNDROME 6 0.0022
326 HYPERBILIRUBINAEMIA 23 0.0022
327 PANCYTOPENIA 124 0.0022
328 SPUTUM DISCOLOURED 21 0.0022
329 MONOCYTE COUNT INCREASED 8 0.0022
330 NAIL DISORDER 19 0.0022
331 PNEUMOPERITONEUM 4 0.0022
332 SECOND PRIMARY MALIGNANCY 18 0.0022
333 OTOTOXICITY 4 0.0022
334 GRANULOCYTE COUNT DECREASED 4 0.0022
335 HYPOMAGNESAEMIA 30 0.0022
336 ADENOCARCINOMA OF COLON 4 0.0021
337 OLIGOHYDRAMNIOS 7 0.0021
338 AGRANULOCYTOSIS 39 0.0021
339 NEPHRITIS 7 0.0021
340 RADIUS FRACTURE 5 0.0021
341 OSTEONECROSIS 68 0.0021
342 ATELECTASIS 20 0.0021
343 IMMOBILE 9 0.0021
344 DISEASE RECURRENCE 98 0.0021
345 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
346 CUTANEOUS LUPUS ERYTHEMATOSUS 4 0.0021
347 CYTOPENIA 25 0.0020
348 GINGIVITIS 11 0.0020
349 LUNG INFILTRATION 18 0.0020
350 ORGANISING PNEUMONIA 10 0.0020
351 PLATELET DISORDER 5 0.0020
352 PSEUDOMONAS INFECTION 17 0.0020
353 PATHOLOGICAL FRACTURE 10 0.0020
354 LIPASE INCREASED 15 0.0020
355 DIVERTICULAR PERFORATION 4 0.0019
356 MULTIPLE-DRUG RESISTANCE 6 0.0019
357 THROMBOCYTOSIS 7 0.0019
358 BRAIN OEDEMA 24 0.0019
359 HEPATIC FAILURE 57 0.0019
360 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 18 0.0019
361 LEUKOENCEPHALOPATHY 7 0.0019
362 GENERAL PHYSICAL HEALTH DETERIORATION 216 0.0019
363 HEPATIC NEOPLASM 6 0.0018
364 LYMPHOPENIA 26 0.0018
365 CANDIDA INFECTION 31 0.0018
366 HYPERAESTHESIA 15 0.0018
367 PLATELET COUNT ABNORMAL 11 0.0018
368 DYSPNOEA EXERTIONAL 68 0.0018
369 HEPATIC ENZYME ABNORMAL 9 0.0018
370 VENOUS THROMBOSIS 7 0.0018
371 ACUTE PULMONARY OEDEMA 10 0.0018
372 PNEUMONIA FUNGAL 7 0.0018
373 CLOSTRIDIAL INFECTION 6 0.0018
374 TOOTH EXTRACTION 22 0.0018
375 COMPUTERISED TOMOGRAM ABNORMAL 4 0.0018
376 NEUTROPHIL COUNT INCREASED 18 0.0018
377 TUMOUR HAEMORRHAGE 5 0.0018
378 JAUNDICE 47 0.0017
379 SEPTIC SHOCK 76 0.0017
380 PULMONARY MASS 26 0.0017
381 SENSORY LOSS 14 0.0017
382 ADENOVIRUS INFECTION 5 0.0017
383 WHITE BLOOD CELL COUNT ABNORMAL 11 0.0017
384 ENTERITIS 11 0.0017
385 PERFORMANCE STATUS DECREASED 8 0.0017
386 EXTRAVASATION 7 0.0017
387 HYPERCALCAEMIA 21 0.0017
388 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
389 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
390 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
391 PROTHROMBIN TIME PROLONGED 10 0.0017
392 BONE MARROW DISORDER 5 0.0017
393 BLOOD ALKALINE PHOSPHATASE INCREASED 41 0.0016
394 CUTANEOUS VASCULITIS 6 0.0016
395 JAW DISORDER 9 0.0016
396 HEPATIC PAIN 7 0.0016
397 PNEUMONIA BACTERIAL 15 0.0016
398 LYMPHADENOPATHY 57 0.0016
399 HYPERAMMONAEMIA 8 0.0016
400 BONE DISORDER 29 0.0016
401 TOXIC SKIN ERUPTION 16 0.0016
402 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
403 TRANSAMINASES INCREASED 35 0.0016
404 BREAST CANCER 146 0.0016
405 STOMATITIS 95 0.0016
406 BLOOD BILIRUBIN INCREASED 42 0.0016
407 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 4 0.0015
408 ASPARTATE AMINOTRANSFERASE INCREASED 82 0.0015
409 TONSILLITIS 8 0.0015
410 PULMONARY EMBOLISM 145 0.0015
411 HYPOKALAEMIA 70 0.0015
412 CYTOMEGALOVIRUS INFECTION 25 0.0015
413 AZOTAEMIA 6 0.0015
414 CARDIAC FAILURE ACUTE 10 0.0015
415 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
416 WOUND DEHISCENCE 5 0.0015
417 TUMOUR LYSIS SYNDROME 13 0.0015
418 HEPATIC CYST 5 0.0015
419 PULSE ABSENT 7 0.0015
420 MOUTH ULCERATION 31 0.0015
421 GASTRIC PERFORATION 4 0.0015
422 C-REACTIVE PROTEIN INCREASED 53 0.0015
423 PLEURITIC PAIN 4 0.0014
424 ACUTE CORONARY SYNDROME 12 0.0014
425 HYPERTHERMIA 11 0.0014
426 GASTROINTESTINAL INFLAMMATION 11 0.0014
427 C-REACTIVE PROTEIN ABNORMAL 9 0.0014
428 NEURALGIA 34 0.0014
429 PYELONEPHRITIS 12 0.0014
430 COMA SCALE ABNORMAL 4 0.0014
431 HEPATIC FUNCTION ABNORMAL 51 0.0014
432 HAEMOPTYSIS 38 0.0014
433 MASS 19 0.0014
434 CHOLESTASIS 26 0.0014
435 HEPATITIS FULMINANT 4 0.0013
436 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 10 0.0013
437 EMBOLISM 11 0.0013
438 ALANINE AMINOTRANSFERASE INCREASED 81 0.0013
439 RESPIRATORY FAILURE 96 0.0013
440 CHRONIC MYELOID LEUKAEMIA 6 0.0013
441 LUNG INFECTION 20 0.0013
442 PULMONARY HAEMORRHAGE 10 0.0013
443 BLOOD CREATININE DECREASED 4 0.0013
444 SEPSIS 142 0.0013
445 THERAPY NON-RESPONDER 57 0.0013
446 FRACTURE 24 0.0013
447 POLYDIPSIA 5 0.0013
448 NON-CARDIAC CHEST PAIN 4 0.0013
449 BACTERAEMIA 15 0.0013
450 PNEUMONIA VIRAL 4 0.0013
451 PULMONARY FIBROSIS 24 0.0012
452 ANGIOPATHY 7 0.0012
453 OCULAR DISCOMFORT 14 0.0012
454 SENSORY DISTURBANCE 20 0.0012
455 PROCTALGIA 8 0.0012
456 LOOSE TOOTH 4 0.0012
457 NEUTROPHILIA 7 0.0012
458 BACTERIAL SEPSIS 4 0.0012
459 MUSCULOSKELETAL CHEST PAIN 19 0.0012
460 HYPOCALCAEMIA 23 0.0012
461 NEUTROPHIL COUNT DECREASED 49 0.0012
462 HAEMODYNAMIC INSTABILITY 9 0.0012
463 GENERAL PHYSICAL CONDITION ABNORMAL 8 0.0012
464 UTERINE HAEMORRHAGE 5 0.0012
465 CEREBRAL ISCHAEMIA 6 0.0012
466 LEFT VENTRICULAR FAILURE 4 0.0012
467 TRISMUS 6 0.0012
468 COLITIS 44 0.0012
469 BLOOD CALCIUM INCREASED 10 0.0011
470 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
471 SKIN FISSURES 22 0.0011
472 BACTERIAL INFECTION 21 0.0011
473 SPLENOMEGALY 13 0.0011
474 VISUAL FIELD DEFECT 8 0.0011
475 SUSPECTED OFF LABEL USE 5 0.0011
476 DERMATITIS BULLOUS 8 0.0011
477 BONE PAIN 64 0.0011
478 SPINAL COMPRESSION FRACTURE 9 0.0011
479 VAGINAL DISCHARGE 11 0.0011
480 RETINOPATHY 4 0.0011
481 CHEMOTHERAPY 4 0.0011
482 BLOOD CREATININE INCREASED 69 0.0011
483 ILEUS 13 0.0010
484 NEOPLASM 12 0.0010
485 EXERCISE TOLERANCE DECREASED 6 0.0010
486 HYPOKINESIA 15 0.0010
487 PYREXIA 355 0.0010
488 RESPIRATORY ACIDOSIS 4 0.0010
489 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
490 HYPERNATRAEMIA 5 0.0010
491 HYPOTONIA 10 0.0010
492 ARTERIOSPASM CORONARY 4 0.0010
493 OSTEOMYELITIS 18 0.0010
494 DRUG INTOLERANCE 96 0.0010
495 DUODENAL ULCER 7 0.0010
496 KLEBSIELLA INFECTION 5 0.0010
497 INFECTION 143 0.0010
498 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
499 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
500 PERIPHERAL ISCHAEMIA 4 0.0010
501 HYPOTHYROIDISM 31 0.0010
502 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 8 0.0010
503 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
504 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
505 SQUAMOUS CELL CARCINOMA 9 0.0010
506 ULCER 15 0.0009
507 SPINAL PAIN 11 0.0009
508 HYDRONEPHROSIS 7 0.0009
509 COMPRESSION FRACTURE 5 0.0009
510 MULTI-ORGAN FAILURE 16 0.0009
511 LIVER DISORDER 41 0.0009
512 CHOLECYSTITIS 11 0.0009
513 DEEP VEIN THROMBOSIS 60 0.0009
514 RESPIRATORY TRACT INFECTION 24 0.0009
515 PRODUCT USE IN UNAPPROVED INDICATION 228 0.0009
516 PAIN IN JAW 26 0.0009
517 HYDROCEPHALUS 5 0.0009
518 HIP ARTHROPLASTY 14 0.0009
519 WHITE BLOOD CELL COUNT DECREASED 99 0.0009
520 ASPIRATION 10 0.0009
521 HYPOXIA 32 0.0009
522 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
523 BLOOD CREATINE INCREASED 4 0.0009
524 NO THERAPEUTIC RESPONSE 11 0.0009
525 HEPATITIS 23 0.0009
526 LIVER INJURY 22 0.0009
527 DECREASED APPETITE 207 0.0009
528 PRODUCT LEAKAGE 5 0.0009
529 CONSTIPATION 194 0.0009
530 LOWER LIMB FRACTURE 17 0.0009
531 MITRAL VALVE INCOMPETENCE 10 0.0009
532 MULTIPLE ORGAN DYSFUNCTION SYNDROME 25 0.0009
533 DRUG TOXICITY 12 0.0009
534 RENAL IMPAIRMENT 74 0.0009
535 SKIN LESION 24 0.0009
536 ACUTE GRAFT VERSUS HOST DISEASE 4 0.0009
537 ANGINA PECTORIS 25 0.0009
538 ISCHAEMIA 4 0.0009
539 UROSEPSIS 8 0.0009
540 TENDERNESS 9 0.0009
541 HEPATIC CYTOLYSIS 11 0.0009
542 MULTIPLE MYELOMA 4 0.0009
543 ANOREXIA 11 0.0009
544 SUDDEN DEATH 9 0.0008
545 VOMITING 399 0.0008
546 LYMPHOCYTE COUNT DECREASED 15 0.0008
547 OEDEMA 46 0.0008
548 RESTLESSNESS 31 0.0008
549 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 60 0.0008
550 CHRONIC LYMPHOCYTIC LEUKAEMIA 4 0.0008
551 RETINAL HAEMORRHAGE 6 0.0008
552 GRAFT VERSUS HOST DISEASE 6 0.0008
553 NERVOUS SYSTEM DISORDER 26 0.0008
554 RASH PUSTULAR 6 0.0008
555 FACIAL PARALYSIS 7 0.0008
556 SKIN HYPERPIGMENTATION 7 0.0008
557 HEPATOMEGALY 8 0.0008
558 DERMATITIS 17 0.0008
559 PSYCHOLOGICAL TRAUMA 7 0.0008
560 STAPHYLOCOCCAL SEPSIS 4 0.0008
561 COUGH 227 0.0008
562 CONJUNCTIVITIS 15 0.0008
563 HAEMATOCRIT DECREASED 16 0.0008
564 CHOLANGITIS 5 0.0008
565 IMMUNODEFICIENCY 12 0.0008
566 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 44 0.0008
567 FISTULA 9 0.0008
568 CYTOKINE RELEASE SYNDROME 16 0.0008
569 DIARRHOEA 514 0.0008
570 ACUTE KIDNEY INJURY 121 0.0008
571 PROTEINURIA 15 0.0008
572 OFF LABEL USE 677 0.0008
573 PERITONITIS 16 0.0008
574 SKIN NECROSIS 4 0.0008
575 VENTRICULAR EXTRASYSTOLES 8 0.0008
576 ASTHENIA 288 0.0008
577 RASH MACULO-PAPULAR 17 0.0008
578 HYPONATRAEMIA 43 0.0008
579 POLYARTHRITIS 4 0.0008
580 ATRIAL FLUTTER 6 0.0008
581 URINARY RETENTION 25 0.0007
582 MENINGITIS 5 0.0007
583 LETHARGY 43 0.0007
584 LIVER FUNCTION TEST INCREASED 16 0.0007
585 CARDIOMYOPATHY 11 0.0007
586 ADRENAL INSUFFICIENCY 9 0.0007
587 CHEILITIS 4 0.0007
588 DYSPHAGIA 70 0.0007
589 BLINDNESS 30 0.0007
590 MUSCULOSKELETAL DISORDER 14 0.0007
591 PNEUMONIA 238 0.0007
592 SKIN ULCER 19 0.0007
593 HAIR DISORDER 6 0.0007
594 CARDIAC FAILURE 58 0.0007
595 STREPTOCOCCAL INFECTION 4 0.0007
596 NIGHT SWEATS 23 0.0007
597 HYPERGLYCAEMIA 26 0.0007
598 LYMPHOMA 11 0.0007
599 BLOOD CALCIUM DECREASED 8 0.0007
600 EYE INFECTION 8 0.0007
601 INTENTIONAL PRODUCT USE ISSUE 62 0.0007
602 THERMAL BURN 5 0.0007
603 TOXICITY TO VARIOUS AGENTS 118 0.0007
604 RED BLOOD CELL COUNT DECREASED 20 0.0007
605 PARALYSIS 10 0.0007
606 EPISTAXIS 52 0.0007
607 HYPOTHERMIA 7 0.0007
608 ELECTROLYTE IMBALANCE 8 0.0007
609 LIVER FUNCTION TEST ABNORMAL 20 0.0007
610 HYPERTRIGLYCERIDAEMIA 4 0.0007
611 WOUND 19 0.0007
612 HERPES ZOSTER 39 0.0007
613 PSYCHOTIC DISORDER 20 0.0007
614 CATARACT OPERATION 4 0.0007
615 MYOSITIS 6 0.0007
616 PLATELET COUNT DECREASED 71 0.0007
617 HEPATITIS CHOLESTATIC 4 0.0007
618 INTESTINAL OBSTRUCTION 25 0.0007
619 ALOPECIA 130 0.0007
620 RENAL FAILURE ACUTE 28 0.0007
621 HAEMOGLOBIN DECREASED 67 0.0007
622 TREATMENT FAILURE 54 0.0007
623 DEVICE RELATED INFECTION 10 0.0006
624 CIRCULATORY COLLAPSE 11 0.0006
625 ACUTE MYOCARDIAL INFARCTION 19 0.0006
626 HAIR COLOUR CHANGES 8 0.0006
627 NAUSEA 506 0.0006
628 LEUKAEMIA 6 0.0006
629 DENTAL CARIES 7 0.0006
630 TRICUSPID VALVE INCOMPETENCE 5 0.0006
631 COLD SWEAT 11 0.0006
632 INTESTINAL PERFORATION 7 0.0006
633 THROMBOSIS 50 0.0006
634 ISCHAEMIC STROKE 11 0.0006
635 DYSPHONIA 36 0.0006
636 DEHYDRATION 82 0.0006
637 MYOCARDITIS 7 0.0006
638 IMPAIRED HEALING 20 0.0006
639 LUNG NEOPLASM MALIGNANT 25 0.0006
640 LEUKOCYTOSIS 11 0.0006
641 GASTROINTESTINAL DISORDER 54 0.0006
642 HAIR TEXTURE ABNORMAL 8 0.0006
643 QUALITY OF LIFE DECREASED 8 0.0006
644 HAEMODIALYSIS 5 0.0006
645 CELLULITIS 30 0.0006
646 TOOTH ABSCESS 6 0.0006
647 DYSPNOEA 332 0.0006
648 ATRIAL FIBRILLATION 57 0.0006
649 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
650 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
651 ONYCHOCLASIS 4 0.0006
652 ORAL PAIN 13 0.0006
653 FATIGUE 452 0.0006
654 ANAPHYLACTIC REACTION 32 0.0006
655 FOLLICULITIS 6 0.0006
656 GASTRITIS 15 0.0006
657 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
658 GROIN PAIN 5 0.0006
659 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
660 INCONTINENCE 6 0.0006
661 FULL BLOOD COUNT ABNORMAL 6 0.0006
662 HEPATOCELLULAR INJURY 8 0.0006
663 ABSCESS 9 0.0006
664 WRONG DRUG ADMINISTERED 5 0.0006
665 THERAPEUTIC RESPONSE DECREASED 34 0.0006
666 OEDEMA PERIPHERAL 68 0.0006
667 CARDIOGENIC SHOCK 8 0.0006
668 PAIN OF SKIN 15 0.0006
669 HAEMATEMESIS 14 0.0006
670 GASTROENTERITIS 8 0.0005
671 MOUTH HAEMORRHAGE 4 0.0005
672 RESPIRATORY DISTRESS 15 0.0005
673 PSYCHIATRIC SYMPTOM 4 0.0005
674 SKIN DISORDER 18 0.0005
675 HYPERTENSIVE CRISIS 6 0.0005
676 PERICARDITIS 9 0.0005
677 HEMIPARESIS 9 0.0005
678 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
679 EPILEPSY 16 0.0005
680 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
681 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
682 MUSCLE TWITCHING 12 0.0005
683 TACHYCARDIA 46 0.0005
684 MADAROSIS 6 0.0005
685 VASCULITIS 6 0.0005
686 GINGIVAL BLEEDING 7 0.0005
687 ACUTE HEPATIC FAILURE 7 0.0005
688 VERTIGO 31 0.0005
689 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
690 RESPIRATORY DISORDER 15 0.0005
691 DIPLOPIA 13 0.0005
692 BLOOD DISORDER 4 0.0005
693 INFUSION RELATED REACTION 33 0.0005
694 LACRIMATION INCREASED 15 0.0005
695 BLINDNESS UNILATERAL 7 0.0005
696 DRUG EFFECT INCOMPLETE 18 0.0005
697 DECUBITUS ULCER 4 0.0005
698 ESCHERICHIA INFECTION 4 0.0005
699 PARAESTHESIA ORAL 7 0.0005
700 PETECHIAE 5 0.0005
701 DRUG-INDUCED LIVER INJURY 15 0.0005
702 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
703 DYSPEPSIA 47 0.0005
704 SKIN PLAQUE 4 0.0005
705 JOINT DISLOCATION 5 0.0005
706 PARAESTHESIA 74 0.0005
707 ACUTE RESPIRATORY FAILURE 9 0.0005
708 ANURIA 4 0.0005
709 HAEMATOMA 12 0.0005
710 WEIGHT DECREASED 129 0.0005
711 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
712 PLATELET COUNT INCREASED 6 0.0005
713 ABDOMINAL PAIN 107 0.0005
714 BACK INJURY 5 0.0005
715 ORTHOSTATIC HYPOTENSION 8 0.0005
716 MELAENA 10 0.0005
717 DYSARTHRIA 17 0.0005
718 LUNG DISORDER 22 0.0004
719 BASAL CELL CARCINOMA 7 0.0004
720 DYSGEUSIA 33 0.0004
721 PRODUCTIVE COUGH 21 0.0004
722 HAEMATURIA 15 0.0004
723 CHEST PAIN 81 0.0004
724 SHOCK 10 0.0004
725 NEOPLASM MALIGNANT 29 0.0004
726 HYPOGLYCAEMIA 21 0.0004
727 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
728 HEPATIC STEATOSIS 8 0.0004
729 NECK PAIN 24 0.0004
730 BACK PAIN 99 0.0004
731 SKIN REACTION 6 0.0004
732 HEPATIC CIRRHOSIS 8 0.0004
733 SINUS TACHYCARDIA 6 0.0004
734 ARRHYTHMIA 20 0.0004
735 RENAL FAILURE 56 0.0004
736 BRONCHOSPASM 6 0.0004
737 LIMB DISCOMFORT 13 0.0004
738 FUNGAL INFECTION 14 0.0004
739 POOR QUALITY SLEEP 9 0.0004
740 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
741 DEPRESSED MOOD 22 0.0004
742 HEPATITIS C 5 0.0004
743 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
744 SCAR 7 0.0004
745 ENCEPHALOPATHY 10 0.0004
746 CARDIO-RESPIRATORY ARREST 17 0.0004
747 CARDIOMEGALY 5 0.0004
748 BODY TEMPERATURE DECREASED 4 0.0004
749 RASH PRURITIC 22 0.0004
750 PALPITATIONS 47 0.0004
751 LOCAL SWELLING 7 0.0004
752 THROAT IRRITATION 18 0.0004
753 DRUG INEFFECTIVE 524 0.0004
754 RASH 172 0.0004
755 CHILLS 46 0.0004
756 HYPOPHAGIA 10 0.0004
757 DEATH 335 0.0004
758 TOOTHACHE 7 0.0004
759 PELVIC PAIN 7 0.0004
760 NODULE 5 0.0004
761 ECZEMA 20 0.0004
762 HYPOAESTHESIA 57 0.0004
763 ORAL CANDIDIASIS 5 0.0004
764 HYPERSENSITIVITY 70 0.0004
765 OBESITY 6 0.0004
766 SCIATICA 6 0.0004
767 BLISTER 21 0.0004
768 CONFUSIONAL STATE 60 0.0004
769 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
770 INFLAMMATION 19 0.0004
771 TACHYPNOEA 5 0.0004
772 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
773 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
774 STAPHYLOCOCCAL INFECTION 12 0.0004
775 VENTRICULAR TACHYCARDIA 6 0.0004
776 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
777 MENTAL STATUS CHANGES 10 0.0004
778 COLITIS ULCERATIVE 16 0.0004
779 SKIN INFECTION 4 0.0004
780 SKIN EXFOLIATION 30 0.0004
781 STATUS EPILEPTICUS 4 0.0004
782 MYOCARDIAL ISCHAEMIA 4 0.0004
783 ERYTHEMA 71 0.0003
784 HYPERTHYROIDISM 5 0.0003
785 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
786 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
787 EYELID OEDEMA 4 0.0003
788 BODY TEMPERATURE INCREASED 7 0.0003
789 JOINT STIFFNESS 9 0.0003
790 URINARY INCONTINENCE 10 0.0003
791 ATAXIA 4 0.0003
792 CEREBRAL HAEMORRHAGE 12 0.0003
793 OROPHARYNGEAL PAIN 31 0.0003
794 BLOOD PRESSURE DECREASED 22 0.0003
795 HYPERTENSION 70 0.0003
796 OSTEOPENIA 5 0.0003
797 DIABETES MELLITUS 25 0.0003
798 RESPIRATORY ARREST 9 0.0003
799 GYNAECOMASTIA 10 0.0003
800 GENERALISED OEDEMA 4 0.0003
801 PHARYNGITIS 4 0.0003
802 PNEUMONIA ASPIRATION 8 0.0003
803 POISONING 4 0.0003
804 BLOOD SODIUM DECREASED 6 0.0003
805 CYANOSIS 5 0.0003
806 RASH ERYTHEMATOUS 15 0.0003
807 HEART RATE DECREASED 11 0.0003
808 ILL-DEFINED DISORDER 19 0.0003
809 RASH PAPULAR 7 0.0003
810 RHINORRHOEA 20 0.0003
811 HEPATIC ENZYME INCREASED 21 0.0003
812 MUSCULOSKELETAL PAIN 16 0.0003
813 URINARY TRACT INFECTION 52 0.0003
814 TOOTH INFECTION 4 0.0003
815 BLOOD PRESSURE ABNORMAL 6 0.0003
816 BRADYCARDIA 16 0.0003
817 MYALGIA 51 0.0003
818 BREAST CANCER FEMALE 8 0.0003
819 DYSURIA 11 0.0003
820 SUICIDE ATTEMPT 18 0.0003
821 CONDITION AGGRAVATED 90 0.0003
822 DISCOMFORT 18 0.0003
823 ADVERSE EVENT 27 0.0003
824 OSTEOPOROSIS 12 0.0003
825 MUSCULOSKELETAL DISCOMFORT 5 0.0003
826 PULMONARY OEDEMA 13 0.0003
827 HYPERKALAEMIA 10 0.0003
828 OXYGEN SATURATION DECREASED 16 0.0003
829 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
830 MOVEMENT DISORDER 9 0.0003
831 SKIN CANCER 6 0.0003
832 PRODUCT USE ISSUE 52 0.0003
833 PAIN IN EXTREMITY 81 0.0003
834 CHOLELITHIASIS 9 0.0003
835 BURNING SENSATION 19 0.0003
836 TOOTH DISORDER 6 0.0003
837 HYPOTENSION 54 0.0003
838 DEAFNESS 7 0.0003
839 SWELLING 25 0.0003
840 VISUAL IMPAIRMENT 33 0.0003
841 HYPOAESTHESIA ORAL 4 0.0003
842 GASTRIC ULCER 5 0.0003
843 CARDIAC FAILURE CONGESTIVE 21 0.0003
844 FEMUR FRACTURE 8 0.0003
845 MOOD ALTERED 7 0.0003
846 HAEMORRHOIDS 5 0.0003
847 SEIZURE 29 0.0003
848 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
849 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
850 FULL BLOOD COUNT DECREASED 5 0.0002
851 DRY MOUTH 20 0.0002
852 PAIN 151 0.0002
853 RIB FRACTURE 5 0.0002
854 TOOTH LOSS 5 0.0002
855 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
856 COAGULOPATHY 4 0.0002
857 AGGRESSION 12 0.0002
858 ABDOMINAL PAIN UPPER 49 0.0002
859 FACE OEDEMA 4 0.0002
860 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
861 HALLUCINATION, VISUAL 5 0.0002
862 MOBILITY DECREASED 17 0.0002
863 CARDIOVASCULAR DISORDER 6 0.0002
864 ANAPHYLACTIC SHOCK 6 0.0002
865 APHASIA 7 0.0002
866 CONVULSION 13 0.0002
867 PRURITUS 87 0.0002
868 STEVENS-JOHNSON SYNDROME 5 0.0002
869 INFLUENZA 25 0.0002
870 SKIN BURNING SENSATION 16 0.0002
871 LIMB INJURY 6 0.0002
872 HAEMORRHAGE 23 0.0002
873 SYNCOPE 22 0.0002
874 MALAISE 96 0.0002
875 CARDIAC ARREST 18 0.0002
876 DEPRESSION 49 0.0002
877 CHEST DISCOMFORT 22 0.0002
878 DRUG INTERACTION 34 0.0002
879 GAIT DISTURBANCE 41 0.0002
880 RECTAL HAEMORRHAGE 9 0.0002
881 LOCALISED INFECTION 5 0.0002
882 EAR PAIN 4 0.0002
883 HEADACHE 128 0.0002
884 BLOOD PRESSURE INCREASED 31 0.0002
885 MUSCULAR WEAKNESS 23 0.0002
886 WHEEZING 12 0.0002
887 DISORIENTATION 8 0.0002
888 ABDOMINAL DISTENSION 21 0.0002
889 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
890 DRY SKIN 26 0.0002
891 UNRESPONSIVE TO STIMULI 5 0.0002
892 RENAL DISORDER 9 0.0002
893 CARDIAC DISORDER 18 0.0002
894 METABOLIC ACIDOSIS 6 0.0002
895 RETCHING 4 0.0002
896 DIZZINESS 93 0.0002
897 DISTURBANCE IN ATTENTION 10 0.0002
898 INTENTIONAL PRODUCT MISUSE 16 0.0002
899 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
900 DEMENTIA 5 0.0002
901 UNDERDOSE 13 0.0002
902 FLUSHING 18 0.0002
903 HEART RATE IRREGULAR 4 0.0002
904 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
905 SKIN DISCOLOURATION 8 0.0002
906 DELIRIUM 6 0.0002
907 COGNITIVE DISORDER 8 0.0002
908 CHRONIC KIDNEY DISEASE 13 0.0002
909 MUSCLE SPASMS 31 0.0002
910 BLOOD POTASSIUM DECREASED 5 0.0002
911 PREMATURE BABY 5 0.0002
912 TREATMENT NONCOMPLIANCE 9 0.0002
913 CEREBRAL INFARCTION 4 0.0002
914 EMOTIONAL DISORDER 5 0.0002
915 INFLUENZA LIKE ILLNESS 13 0.0002
916 CYSTITIS 5 0.0002
917 TREMOR 26 0.0002
918 SOMNOLENCE 31 0.0002
919 NASOPHARYNGITIS 28 0.0002
920 CATARACT 9 0.0002
921 AGITATION 11 0.0001
922 FEAR 4 0.0001
923 ABDOMINAL DISCOMFORT 24 0.0001
924 RASH MACULAR 5 0.0001
925 WEIGHT INCREASED 32 0.0001
926 INJURY 10 0.0001
927 ARTHRALGIA 59 0.0001
928 HYPOACUSIS 6 0.0001
929 MENTAL DISORDER 6 0.0001
930 FLUID RETENTION 7 0.0001
931 ACCIDENTAL OVERDOSE 5 0.0001
932 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
933 ANXIETY 38 0.0001
934 PANCREATITIS 7 0.0001
935 FALL 44 0.0001
936 CORONARY ARTERY DISEASE 4 0.0001
937 COVID-19 23 0.0001
938 BALANCE DISORDER 11 0.0001
939 COMA 6 0.0001
940 MUSCULOSKELETAL STIFFNESS 11 0.0001
941 OVERDOSE 27 0.0001
942 EYE DISORDER 4 0.0001
943 BRONCHITIS 9 0.0001
944 SURGERY 7 0.0001
945 ACNE 9 0.0001
946 OSTEOARTHRITIS 5 0.0001
947 PERIPHERAL SWELLING 18 0.0001
948 VISION BLURRED 16 0.0001
949 MYOCARDIAL INFARCTION 20 0.0001
950 SPEECH DISORDER 6 0.0001
951 FEELING HOT 7 0.0001
952 ARTHROPATHY 6 0.0001
953 AMNESIA 7 0.0001
954 HALLUCINATION 8 0.0001
955 INSOMNIA 28 0.0001
956 ARTHRITIS 8 0.0001
957 CEREBROVASCULAR ACCIDENT 17 0.0001
958 JOINT SWELLING 12 0.0001
959 EXPOSURE DURING PREGNANCY 6 0.0001
960 LOSS OF CONSCIOUSNESS 12 0.0001
961 HEART RATE INCREASED 9 0.0001
962 TINNITUS 4 0.0001
963 SLEEP DISORDER 6 0.0001
964 BLOOD GLUCOSE DECREASED 4 0.0001
965 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
966 INJECTION SITE ERYTHEMA 10 0.0001
967 DRY EYE 4 0.0001
968 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
969 SINUSITIS 8 0.0001
970 ADVERSE DRUG REACTION 7 0.0001
971 NERVOUSNESS 4 0.0001
972 EMOTIONAL DISTRESS 9 0.0001
973 HOSPITALISATION 11 0.0001
974 FLATULENCE 4 0.0001
975 HYPERHIDROSIS 9 0.0001
976 BLOOD GLUCOSE INCREASED 12 0.0001
977 INJECTION SITE HAEMORRHAGE 5 0.0001
978 CONTUSION 6 0.0001
979 FEELING ABNORMAL 14 0.0001
980 INJECTION SITE REACTION 4 0.0001
981 HOT FLUSH 4 0.0001
982 NO ADVERSE EVENT 9 0.0000
983 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
984 ASTHMA 5 0.0000
985 RHEUMATOID ARTHRITIS 5 0.0000
986 SUICIDAL IDEATION 4 0.0000
987 MEMORY IMPAIRMENT 5 0.0000
988 INCORRECT DOSE ADMINISTERED 6 0.0000
989 URTICARIA 4 0.0000
990 INJECTION SITE PAIN 6 0.0000